Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 16 Other PhD Projects, Programmes & Scholarships in Belfast

Discipline

Discipline

Medicine

Location

Location

Belfast  United Kingdom

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


Other PhD Projects, Programmes & Scholarships in Belfast

We have 16 Other PhD Projects, Programmes & Scholarships in Belfast

Last chance to apply

Dissecting the interface between Klebsiella pneumoniae and lung immune cells in vivo and the effect of new therapeutics.

  Research Group: Wellcome-Wolfson Institute for Experimental Medicine
This collaborative PhD between GSK-Siena and the laboratory of Professor Jose Bengoechea at Queen’s University Belfast, is aimed at undertaking a multidisciplinary… Read more

Microfluidic Encapsulation of biologics into Nanomedicines

Progress in drug design has led to the development of new peptides, proteins, and drug molecules. However, the limited ability to deliver selectively these molecules at well-defined dosing regimens and without invoking drug-resistance remains a significant challenge. Read more

Designing and evaluating novel nanotherapeutics to enhance the effectiveness of radiotherapy in the treatment of solid cancers.

One in two cancer patients will receive radiotherapy as part of their treatment. For patients with a localised cancer diagnosis effective radiotherapy represents the best chance of a curative outcome, however, is not without risk. Read more

Selective targeting of furin for the treatment of fibrotic lung disease.

Furin, a proprotein convertase has been established as a therapeutic target across several disease areas to include chronic airways diseases and infectious disease, such as COVID-19 (reviewed in our recent publication, Douglas et al, 2023). Read more

Peptide-based nanoparticles for brain targeted gene delivery.

Gene therapy has the potential to provide therapeutic benefit to millions of people with neurodegenerative diseases and cancer. Delivery into the brain is hampered by the blood-brain barrier (BBB), which limits the efficacy of both conventional and novel therapies at the target site. Read more

Investigation of the role of STAMBP as a therapeutic target in oesophageal cancer

  Research Group: The Patrick G Johnston Centre for Cancer Research
Publicly available data from CRISPR knock out screens in hundreds of cell lines suggests a strong dependency on STAMBP in oesophageal cancer. Read more

Targeting IRF4 in Multiple Myeloma using Molecular Glues

  Research Group: The Patrick G Johnston Centre for Cancer Research
The IRF4 transcription factor represents a potential novel target in multiple myeloma but to date, it has not been druggable. This project aims to identify molecular glues that can lead to the specific degradation of IRF4. Read more

Developing biodegradable long acting drug delivery systems for the treatment of chronic conditions

Non-adherence to treatment costs the NHS more than £500M each year. Adherence is especially important when treating patients with chronic conditions that require lifetime pharmacological treatment, such as schizophrenia, Parkinson’s disease, HIV and Alzheimer’s disease. Read more

Self-regulating, self-cleaning biomaterials

A major problem associated with medical devices is infection. With infection rates of approaching 100% in some devices, ways to prevent formation of bacterial biofilm on medical device surfaces are urgently required. Read more

Self-Navigating Nanocarriers for Intracellular Protein Delivery

Protein-based therapeutics have shown remarkable success in modulating extracellular targets; however, effective intracellular delivery remains a key challenge in biotherapeutics. Read more

Self-Navigating Nanocarriers for Intracellular Protein Delivery

Protein-based therapeutics have shown remarkable success in modulating extracellular targets; however, effective intracellular delivery remains a key challenge in biotherapeutics. Read more

Assessing the molecular mechanisms by which Cathepsin V promotes breast cancer growth and metastasis

Targeted therapies such as tamoxifen, fulvestrant and anastrozole have exhibited significant clinical success since being introduced as treatments for Estrogen Receptor positive (ER+) breast cancer patients. Read more

Filtering Results